Wealthy investors are flocking to artificial intelligence startups — and fueling a private market renaissance.

We’re at this tipping point” for AI in biology, Eran Segal, a computational biologist at the Weizmann Institute of Science and a collaborator of Xing’s, told me. “All the stars aligned, and we have ...